Power Law company profile

Capstan Therapeutics

Biotech & Life Sciences · San Diego, United States · Founded 2021 Unicorn

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$1–2.5B

Latest valuation · 2026

Unlock exact value

Headcount

<100

Current team size

Unlock exact value

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Advancing cell engineering to develop therapeutics for a broad range of diseases

Investors

16 investors on Capstan Therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 4 investors entered at this stage

RA Capital Management

Novartis Venture Fund

Vida Ventures

OrbiMed

Series A 6 investors entered at this stage

Bristol-Myers Squibb

Eli Lilly

Leaps by Bayer

Pfizer Ventures

Polaris Partners

Alexandria Venture Investments

Series B+ 6 investors entered at this stage

University of Pennsylvania

Forbion Capital Partners

Sofinnova Investments

Mubadala Capital

Johnson & Johnson Innovation

Perceptive Advisors

Global footprint

Where Capstan Therapeutics has talent and traffic

Workforce by country

2 countries with
team presence

🇺🇸 United States98.6%

🇳🇱 Netherlands1.4%

2 countries shown

Web traffic by country

230 monthly visits
across markets

🇺🇸 United States87%

Top 1 markets shown

Patent intelligence

$108k patent portfolio · 6 active families

Estimated portfolio value

$108k

<0.01% of valuation · 43.1× smaller than top peer Orna Therapeutics ($5M)

6 active patent families

Where Capstan Therapeutics innovates NanoparticleMolecular biologyNucleic acidEx vivoCell type

Where Capstan Therapeutics concentrates vs peers

Each axis is a top-10 topic across Capstan Therapeutics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Sentiment on X

What X is saying about Capstan Therapeutics

An AI-synthesized read of the highest-engagement posts about Capstan Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Capstan Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles